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Cells of the mononuclear phagocyte system arise from circulating blood monocytes.
Upon emigration from the vasculature, monocytes differentiate into macrophages, a pro-
cess that monocytes similarly undergo in vitro. We have established primary cultures
from elutriated or adherence-purified blood monocytes and analyzed the antigenic mod-
ulation during monocyte to macrophage transformation, which could be followed by the
expression of specific antigens and which required as yet unknown inducer signals
present in the serum. It is shown that in the absence of serum monocytes only survive in
vitro when cultured adherent to plastic but rapidly die in suspension culture. Starting at
0.5%, serum induced maturation dose-dependently, with the optimal concentration being
2 to 5%. of those antigens not present on monocyte, the low-affinity Fc receptor (CD1 6),
the ca-chain of the vitronectin receptor (CD51), gp65-MAX.1, and gp68-MAX.3 were ex-
pressed only upon serum-induced macrophage differentiation, whereas the transferrin
receptor (CD71), MAX.26, and to some degree also gp65-MAX.11 appeared to be inde-
pendent of maturation and were also found on primary cultures of adherent monocytes
under serum-free conditions. In addition, the rapid induction of HLA class II antigens
(within 24 hr) was similar with and without serum, as was the continued high-density
expression in long-term culture. The monocyte-specific CD14 antigen was down-regu-
lated in the absence of serum but kept its level of expression on differentiated macro-
phages. In comparison, alveolar and peritoneal macrophages, respectively, differed in
their antigenic phenotype: Alveolar macrophages expressed high HLA class II antigens
but low CD14, whereas for peritoneal macrophages the opposite was found. Both inter-
feron--y and - suppressed macrophage maturation in vitro but had contrary effects on
HLA class II and CD16 expression: lnterferon--y up-regulated the two types of antigens,
which, in contrast, were down-regulated by interferon-a.
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INTRODUCTION
The many biological functions that are attributed to
cells of the mononuclear phagocyte system (MPS) Il-SI
all depend on the successful completion of the differen-
nation pathway from immature precursor cells to the ma-
ture macrophage (MAC). Circulating blood monocytes
(MO) emigrate into extravascular tissue sites either to
become resident organ-specific MAC or to be recruited
as immune effector cells at sites of inflammation, injury.
allograft. or tumor rejection. respectively. Monocyte to
macrophage differentiation also occurs in vitro [6,7] in
the presence of as yet undefined serum factors [8-10].
As cell differentiation is modulated in situ by the site-
specific microenvironment that is responsible for the de-
velopment of cell heterogeneity within the MPS, MAC
derived in vitro from blood MO may represent yet an-
other distinct differentiation stage. However, in vitro
maturation has proven to be a very useful model for
studying possible regulatory mechanisms involved in
MAC terminal differentiation as well as the functional
and phenotypic changes that accompany it 16,7,10-141.
In this report we have analyzed the antigenic phenotype
of MAC derived from MO in culture on plastic or hy-
drophobic teflon foils and have evaluated those antigens
indicative of serum-induced MAC differentiation and not
expressed on primary MO cultures established in the ab-
sence of serum. We also investigated the influence of
interferons (IFN) on MAC maturation in vitro. It was
found that these mediators, while inducing functional
activation, inhibited cell differentiation.
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MATERIALS AND METHODS
Monocyte Isolation
Mononuclear cells (MNC) were isolated from buffy
coat preparations or cytapheresis concentrates of healthy
blood donors by density gradient centrifugation over
Ficoll-Hypaque. They were washed twice in RPMI 1640
(supplemented with 20 iM 2-mercaptoethanol. 2 mM
L-glutamin, 50 U/ml penicillin, and 5 ig/ml streptomy-
cm), and the monocytes were separated either by coun-
tercurrent centrifugal elutriation (CCE) in a Beckman
J2/2l or by adherence to plastic surfaces, respectively
[10]. For CCE, cells were resuspended in phosphate-
buffered saline (PBS) with 5% clinical grade human al-
bumin and loaded in a volume of 50 ml onto the elutriator
at 10 ml/min and 2,500 rpm using a standard elutriation
chamber. With stepwise increase of flow (0.5 mI/mm
every 50 ml), MO elutriated at 15 ml/min with a purity
of more than 90% as judged by morphology and CD14
expression. Alternatively, 5 x 106 MNC/ml were cul-
tured in suppl. RPM! 1640 plus 10% fetal calf serum
(FCS) for 60 mm in plastic tissue culture flasks (Fa.
Greiner, Nurtingen, FRG) before the nonadherent cells
were removed with two washes in warm medium. The
adherent cells were cultured overnight in suppl. RPM!
1640 plus 5% human AB-group serum pooled from dif-
ferent pretested donors. The cells could then be washed
completely off the flasks after cooling them down to 4#{176}C
for 30 mm. They proved to be MO with a purity of more
than 90%, and they accounted for about 65% of the
circulating monocyte population.
Explanted Macrophages
Cells were isolated from the bronchoalveolar lavage
fluids of healthy volunteers (both smokers and nonsmok-
ers) or from ascites fluids secondary to portal hyperten-
sion or malignancy. Volunteers and patients had given
informed consent prior to cell collection.
Monocyte Culture
Elutriated or adherence-purified MO were seeded ei-
ther into hydrophobic teflon bags at a concentration of 3
x I0 cells/ml or into 96 well microtiter plates (Greiner)
at l0 cells/0.2 ml suppl. RPM! 1640 with or without AB
serum at a concentration of 2% or as indicated [10,15].
In some experiments human heparinized plasma was
used as culture additive. Cultures were set up in some
experiments with different concentrations of recombi-
nant human interferon (rhIFN)-y (IMMUNERON’TM,
Biogen, Geneva, Switzerland) and rhIFN-a2 (Emil-
Bohringer Institut f. Arzneimittelforschung, Vienna,
Austria). The units of recombinant materials were cal-
culated based on the information provided by the man-
ufacturers. In some experiments serum was replaced by
0. 1 mg/ml lactalbumin hydrolysate, 0.2 mg/ml fetuin,
and 0.15 IU/ml bovine insulin (LIF; materials all from
Sigma Chemicals, St. Louis, MO).
Surface Antigen Expression Analysis With the
Enzyme-Linked Immunosorbent Assay (ELISA)
As described previously I 15], MO and MAC were
analyzed at indicated days of culture for antigen expres-
sion in the microtiter plates in which the cultures were
initiated. For freshly seeded MO (at day 0 for elutriated
cells and at day 1 for adherence-purified cells) as well as
peritoneal and alveolar lavage MAC, respectively, cells
were first incubated for 30 mm in suppl. RPMI 1640 plus
2% AB serum (explanted MAC from alveolar space and
peritoneal cavity at 2 x l0 per ml, MO at l0 per nil)
before being subjected to cell ELISA. Cells were then
fixed at 4#{176}Cwith 0.05% glutaraldehyde for 10 mm. Trip-
licates were incubated with the following monoclonal
antibodies (mAb) diluted in gelatin (0.2%)-containing
medium: Anti43,-microglobulin (b2M) and LeulO
(HLA-DQ Becton and Dickinson, R#{246}dermark, FRG):
My4 (CDl4 Coulter Immunology, Hialeah, FL); OKT9
(CD7 1 ; Ortho Diagnostics, Raritan, NJ), TO22 (HLA-
DQ) and TO39 (HLA-DR/DP Biotest, Dreieich, FRG);
MAX.1 (gp65), MAX.3 (gp68), MAX.II (gp65).
MAX.21 (HLA-DR), MAX.26 (our laboratory)
I 12, 16, 17]; 13C2 and 23C6 (CDS 1  gift of Dr. M. Hor-
ton, Imperial Cancer Research Fund Laboratories, Lon-
don, England) [18]; and CLB FcR gran I (CD16: Dr. P.
Tetteroo, Netherlands Red Cross Blood Transfusion 5cr-
vice, Amsterdam) [19]. As controls, mAb of different
immunoglobulin ( Ig) types raised against cytoplasmic
antigens of Salmonella enteritidis 1 1RX [20] were used.
Immunoperoxidase staining was done using phenyl-di-
amine-dichloride as the substrate. Data are expressed as
OD486 corrected by the values measured in control wells
without the first antibody, mean of triplicate values,
S.D. >15%, but in most experiments an antigen expres-
sion index (AEI) was calculated as percentage of b2M
expression.
Immunoperoxidase Staining on Adhesion Slides
At different stages of culture MAC of more than 95%
purity were recovered from the teflon bags by needle
aspiration. As described recently 1121, cells were at-
tached to Alcian blue-coated slides, prefixed in 0.05%
glutaraldehyde, and incubated with mAb. A four-layer
peroxidase-antiperoxidase (PAP) technique was applied
followed by postfixation with Os04.
RESULTS
Monocytes were isolated from other mononuclear
blood cells either by countercurrent elutriation or by ad-
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TABLE 1. Cell Survival In Primary Human Monocyte
Dependence on the Culture SubstratV
Cultures:
Serum LIF None
Teflon cultures 69 9 0.37
Plastic cultures 2.18’ 1.81 2.06
‘Monocytes purified by centrifugal elutriation were cultured at l0 per
0.2 ml for 7 days in suppl. RPMI 1640 with or without 5% AB group
serum or defined additives (LIF). respectively.
“Data from teflon-cultured cells are expressed as percentages of cells
recovered from the total cell number seeded initially.
‘Cultures in plastic microtiter plates were subjected to cell ELISA
analysis of b2M expression. Data are given as optical density (OD),
mean of triplicates.
herence to plastic surfaces at a purity of <90%. Recov-
cry of MO from buffy coat preparations was consistently
higher by elutriation than by adherence separation, sug-
gesting the existence of a considerable portion of non-
adherent MO. Survival and recovery of MO-derived
MAC after a culture period of 7 days depended on the
substrate.
Serum was essential for MAC survival in cultures on
hydrophobic surfaces and induced the development of
fully differentiated MAC as judged by typical morphol-
ogy and the expression of maturation-associated anti-
gens [12, 14] (shown below). In the absence of serum,
however, cells died; this could only slightly be
prevented by the addition of serum-replacement addi-
tives (Table I ). If MO were cultured on plastic surfaces
(96 well microtiter plates), cells survived as seen from
the expression values of b2M (Table 1 ) but did not
undergo transformation to MAC and retained their
monocytoid morphology. Monocyte to MAC differenti-
ation occurred in cultures of either unseparated MNC
and elutriation- or adherence-purified MO, with the
latter preparation resulting in the poorest recovery rate
and the lowest density of the maturation-associated
antigen gp65-MAX. 1 as detected by the cell ELISA
technique (Table 2).
We have analyzed more than 200 mAbs regarding
their differential reactivity with freshly isolated MO and
teflon-cultured MAC, respectively. We have reported
that only 6 of 150 antimyeloid mAbs submitted to the
Third Leukocyte Differentiation Antigen Workshop
reacted selectively with mature MAC [21]. Here we
demonstrate the a-chain of the vitronectin receptor
(CD5 1, 13C2, and 23C6) 118] to be expressed on MAC
derived from MO in culture (Fig. 1) as well as the
low-affinity receptor for monomeric IgG (CD16; Fig.
2). In figures 1 and 2 values for antigen expression are
depicted as both percentage of positive cells and antigen
density determined by cell ELISA. Independent of the
process of maturation, i.e. , whether MO were cultured
with or without serum, expression of HLA class II
molecules increased rapidly already after 24 hr of
culture and retained their level of b2M-related expres-
sion during the 7 day culture period (Fig. 3) and beyond
(data not shown in detail). When, in comparison, HLA
expression was quantitated on exudate-type MAC
obtained from the peritoneal cavity and the broncho-
alveolar space, respectively, it was evident that
these cells represent two different subpopulations
with distinct antigenic profiles (Table 3). Lung MAC
had much higher HLA class II expression, whereas
CD14 expression was consistently higher in peritoneal
MAC.
To distinguish antigens that are associated with MO to
MAC maturation in vitro from those that (in the absence
of cell maturation) are induced by the culture environ-
ment, we compared antibody reactivity in plastic adher-
entmonolayers of MO cultured in the presence or ab-
sence of serum, respectively. As can be seen from Figure
3, the early up-regulation and the persistent high expres-
sion of HLA class II antigens are similar for serum-
containing and serum-free MO cultures. For the other
antigens tested it was found that MAX.26 and the trans-
ferrmn receptor are independent of MAC maturation,
whereas gp65-MAX. 1 , gp68-MAX.3, CD5 1 ( 13C2),
CD16, and gp65-MAX. 1 1 , though to a lesser degree, are
specifically associated with serum-induced cell differen-
tiation (Table 4). The MO-specific CD14 molecule de-
creases in the absence of serum but retains its expression
in serum-containing cultures (peripheral blood MO cx-
pressing CD14 at about 70 AEI [15]). Thus MAX. 1 but
not CD7 I expression can be used to quantify the degree
of maturation induced by different concentrations of se-
rum and plasma, respectively, as can be seen from Fig-
ure 4.
When MO were cultured in the presence of !FN,
profound effects on maturation and cell phenotype were
observed: Both IFN-a and IFN-y suppressed the
development of the maturation-associated phenotype
(MAX. 1  l3C2 ) with the extent of inhibition varying
consistently from experiment to experiment, especially
for IFN-y. This, we believe, most probably reflects do-
nor-to-donor variation, a phenomenon that is frequently
encountered also by groups studying human macrophage
biology [22]. Figure 5 shows a representative experiment
in which a substantial inhibition of MO to MAC matu-
ration by IFNs could be observed. IFN-y in parallel to its
suppressive effect on cell differentiation substantially ac-
tivated MAC tumor cytotoxicity [13] (data not shown in
detail here) and induced an increased expression of HLA
class II (Fig. 5) and CDI6 (Fig. 6) antigens. In contrast,
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TABLE 2. Phenotype Analysis of Human MAC Maturation on Hydrophobic Teflon:
Dependence on Monocyte Isolation Techniques
Cell type MNC Adherent MO Elutnated MO
Antigen-positive cells
recovered (e/)
b2M 58h 40 70
HLA-DR 55 38 66
HLA-DQ 46 20 35
gp65-MAX. 1 52 38 63
Quantitated antigen
expression (OD)’
b2M 1278d 0.89 1.361
HLA-DR 1.267 0.845 1.32
HLA-DQ l.X)3 0.401 0.531
gp65-MAX.l 0.533 0.232 0.442
MNC or MO purified either by adherence or by centrifugal elutriation were cultured in suppl. RPMI 1640
plus 2% AB serum for 7 days at 5 X l05/ml for MO and 2 x lO#{244}/mlfor MNC, respectively.
hData are expressed as percentage of positive cells recovered from the total cell number seeded in the
teflon bags initially.
“Antigen expression was evaluated by cell ELISA on 2 x l0 MAC.
dData are given as OD values corrected by cell recovery rate in percentage. mean of triplicate values.
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Fig. 1 . Expression of vitronectin receptor (CD51) on in vitro
differentiating MO-derived MAC. Adherence-purified MO were
cultured in teflon bags at 3 x iO cells/mI suppl. RPMI 1640 with
5% AB serum, harvested at indicated days, and subjected to
surface antigen analysis by Immunoperoxidase staining of sin-
gle cells using the mAbs 13C2 and 23C6 (left). Data are given
as mean percentage of antigen-positive cells. Also, 2 x io
MO-derived MAC per well on day 9 of culture were subjected to
cell ELISA (right). Data are given as antigen expression index
(AEI).
DISCUSSION
Within the MPS the circulating blood MO represents
an immature precursor cell that is ready to undergo fur-
ther differentiation upon migration from the vasculature
into the various tissues and body cavities [1,2]. Most
likely initiated through attachment to and interaction
with endothelial cells [23], MO migration may be di-
rected by chemoattractant signals originating from sites
of infection or tumor growth, or it may follow intrinsic
programs of differentiation [24] to result in the genera-
tion of organ-specific populations of resident MAC [25].
Fig. 2. Expression of the CD1 6 molecule (low affinity Fc recep-
tor) on in vitro-differentiating MO-derived MAC. Adherence-pu-
rified MO were cultured either In teflon bags (at 3 x iO cells/mI)
or in plastic microwell plates (at 1O cells/O.2 ml) in suppl. RPMI
1640 plus 5% AB serum. At indicated days antigen expression
was analyzed on single cells and on cell monolayers grown in
microwells, respectively. Data are given as percentages of pos-
itive cells and as specific OD per monolayer, respectively.
Maturation of MAC from MO in vitro in many aspects
resembles the in vivo situation and facilitates investiga-
tion of the modulation and the functional significance of
the differentiation process [6,7,11-131.
In the present investigation we show that considerable
changes occur in the antigenic phenotype when MO are
induced to differentiate in vitro and confirm the results of
others [8,9] that serum is essential for this MO to MAC
transformation, though its active fraction(s) have not
been successfully identified. In the absence of serum.
MO do not develop into MAC; they only survive when
cultured adherent to plastic surfaces and rapidly die in
suspension cultures on hydrophobic teflon membranes
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TABLE 4. Primary Cultures of Human MO-MAC:
Maturation-Associated Antigens as Distinct From
Culture-Induced Antigensa
Expression of
Antigen AB serum None





TFR (CD7 1; OKT9) 78 84
VNR (CD5I: I3C2) 43 9
Fig. 3. Expression of 32-microglobulin (b2M) and HLA class II
antigens on freshly isolated MO, cultured for 24 hr and after
long-term cultivation (8 days). Elutriated MO were seeded at iO
cells/O.2 ml in plastic microplates and analyzed immediately or
after various times of culture without and with 2% AB serum,
respectively. Data are given as specific OD for the expression of
b2M and as antigen expression index (AEI) for HLA class II
antigens.
TABLE 3. Expression of HLA and CD14
Alveolar and Peritoneal Macrophages
Antigens on Human
Alveolar MAC Peritoneal MAC
Antigen (n = 10) (n = 5)
b2M 1.628 ± 0.44h 1.498 ± 0.17
CDI4 48 ± 27’ 85 ± 8
HLA-DR 115 ± 12 72 ± 13
HLA-E)R/DP 129 ± 21 81 ± II
HLA-DQ (TV22) 96 ± 12 33 ± 13
HLA-E)Q (LeulO) 41 ± 5 II ± 6
Monocytes were elutriated and cultured fir 7 days at l0/0.2 ml
suppl. RPMI 1640 in microtiter plates with and without 2% AB serum.
Cell ELISA was used to evaluate antigen expression as described.
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Fig. 4. Expression of gp65-MAX.1 (A) and transferrin receptor
(OKT9; CD71 ; B) on MO/MAC cultured in the presence of van-
ous concentrations of serum/plasma. Elutniated MO were
seeded at io cells/0.2 ml suppl. RPMI 1640 with indicated con-
centrations of serum or hepaninized plasma and cultured for 7
days. Antigen expression was then analyzed by cell ELISA and
given as the antigen expression index, mean of triplicate val-
ues, SD <15%.
vival in vitro is clearly different from cell differentiation.
It is noteworthy that adherence per se may not be suffi-
cient to induce autocrine factor secretion, as the majority
#{149}SERUM
a PLASMA
CelIs were isolated from the bronchoalveolar lavage fluids of healthy
volunteers (both smokers and nonsmokers) or from ascites fluids sec-
ondary to portal hypertension or malignancy.
hMAC 2 x l0 was seeded into microtiter plates and subjected to cell
ELISA analysis. Data are given as specific OD, mean of triplicate
values per test saniple.
‘Data are expressed as percentage of b2M expression (antigen expres-
sion index).
induced by cell adherence, as has been shown recently
for CSF-l [26], c-fos [26], TNF [26], IL-l 127], and
many other, as yet unidentified proteins [28]. CSF-l is
likely to be involved in MO survival, as addition of
neutralizing antibodies to serum-containing cultures led
to cell death [29]. However, addition of exogenous CSF-
I to serum-free cultures cannot induce maturation but
prevents cell death in teflon cultures [29]. Thus cell sur-
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process of MO to MAC maturation in vitro [30].
In studying MO to MAC transformation in vitro it is
essential to distinguish those antigenic changes that are
associated with serum-induced true maturation from
those that are culture induced. As depicted in Figure 3A,
MAC maturation can be exactly quantified by the cx-
.
presson of an antigen reactive with the MAX. 1 mAb.
This antigen is also detected, though at a different
epitope, by the MAX. 1 1 mAb, has a molecular weight of
65 kD, and, like CD14 [3 1 ], seems to be a phosphati-
dylinositol-linked membrane protein (S. Gadd, personal
communication) with an as yet unknown function. In
contrast, the transferrmn receptor (CD7 1 ), though also
absent from MO [14], is expressed independently of se-
yet unknown autocrine factors or signals generated fromrum-induced maturation and is obviously i duc by as
the culture environment (Fig. 3B). Similarly. other an-
tigens originally believed to be restricted to MO-derived
MAC were observed to be expressed on cultured MO to
the same density (defined by the mAb MAX.26) as on
Fig. 5. Phenotype analysis of MO/MAC cultured in the pres-
ence of recombinant interferon-’y and -a. Elutriated MO were
cultured for 7 days at iO cells/0.2 ml suppl. RPMI 1640 with 1%
AB serum in the absence or presence of 200 lU/mI rhlFN-y or
rhIFN-a2, respectively. Expression of b2M, CD14 (My4), HLA
class II (MAX.21, TU22, LeulO), MAX.1, and 13C2 was analyzed
mature MAC or at least at detectable levels (gp6S-
MAX. 1 1). Likewise, the rapid increase in b2M and HLA
class II expression already after a 24 hr culture period is
independent of serum, as is their continued high expres-
sion over long-term culture (Fig. 4). This may reflect the
by cell ELISA. Data are given as the antigen expression index
calculated on the basis of b2M expression (see Materials and
Methods).
functional requirements that MO are subjected to in vivo
when they enter inflammatory sites, i.e. , to be able to
cooperate effectively with the specific immune system
by processing and presenting antigen 131. It is also pos-
OD sible that MO to MAC maturation proceeds via distinct
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Fig. 6. Differential effects of interferon-’y and -a On the expres-
sion of CD16 by in vitro matured MAC. Elutriated MO were cul-
tured for 7 days in suppl. RPMI 1640 with 1% AB serum and
various concentrations of rhlFN-y and rhlFN-a2, respectively.
For other details, see Figures 4 and 5.
of MO also adheres (though loosely) to the teflon mate-
rial. Similarly, different effects were observed for MO
adherent to plastic vs. adherent to connective tissue cells
differentiation stages, with the early, serum-independent
phase being more related to functional activation as re-
flected by the induction of HLA antigens, i.e. , the in-
flammatory-type of MAC. This step may be consistent
with the  ‘veiled accessory cell’ ‘ described by Peters et
al. [32]. A further serum-dependent progression may
then lead to the mature resident MAC type ofcell. In this
respect, activating signals like the T-lymphokine IFN-y
or the monokine IFN-a suppress this progression from
class II expression even further. Thus, activation maythe early (“inflammatory”) differentiation s age to themore mature f rm and, at the same time, induces HLA
exclude MO from maturation. IFN-a, when compared
with IFN-’y. exerts similar and in most experiments
stronger inhibitory effects on MAC maturation but. in
contrast to IFN-y, does not induce HLA class II antigens
and may fix cells at the differentiation stage of the cir-
culating MO.
Whereas IFN-y therefore primes MAC to act within
the specific immune network, IFN-a seems to have the
opposite effect. Thus our work confirms early observa-
tions of the inhibitory effects of IFN on MAC maturation
in vitro [33,34]. In addition, very effective inhibition of
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MO to MAC transformation is also seen with bacterial
endotoxins [35], another stimulus for MAC functional
activity. Unlike other investigators [36,37], we did not
observe down-regulation of CD14 antigens by IFN-y. A
decrease in CD14 expression, however, was most pro-
nounced after 24 hr cultivation and might thus be a con-
sequence of functional activation. In contrast, we studied
the long-term effects of IFN-y on MAC cell differentia-
tion over a period of 7 days.
It is of interest that in situ matured MAC from the
alveolar space and the peritoneal cavity differed consid-
erably. The alveolar MAC, which are in constant contact
with inhaled immunogens, seem to be highly competent
for immunological cooperation as reflected by their high
expression of HLA class II molecules. The peritoneal
MAC express much lower HLA class II antigens but
nearly double as much as the alveolar MAC of the con-
stitutive MAC antigen CD14.
Upon culture MAC obviously can express some lin-
cage-associated antigens still being repressed on circu-
lating MO I 12, 14, 16]. The appearance on mature MAC
of antigens originally described to be specific for osteo-
clasts [ 18] supports the hypothesis of these cells belong-
ing to the MPS and sharing a common precursor cell [2].
A phenotype analysis of MO to MAC maturation thus
can assist in the uncovering of as yet unproven lineage
assignments.
Phenotype analysis can also help to understand the
functional changes that occur in situ upon MAC matu-
ration. For example, mAbs l3C2 and 23C6 both have
been characterized at the Fourth Leukocyte Differentia-
tion Antigen Workshop [38] to recognize the a-chain of
the vitronectin receptor (VNR). This molecule mediates
cell-cell adhesion, is involved in the binding of coagu-
lation factors, and seems to modulate the lytic activity of
complement [39,40]. In the interaction of MAC with
endothelial, mesenchymal, but also lymphoid immune
effector cells the expression of the vitronectin receptor
might be of importance, especially during local inflam-
matory processes. It should be noted here that, similarly,
fibronectin, as another cytoadhesive molecule also ap-
peared to be a maturation-associated MAC product
[13,41].
In addition, the low-affinity receptor for IgG (FcRIII;
CD 16) is expressed on end-stage differentiated MAC
(Table 2; P. Tetteroo, personal communication) [42,43].
This molecule seems to be important for that part of
MAC tumor cytotoxicity that is triggered upon Fc recep-
tor-mediated binding to tumor-associated antibodies
[42]. Thus any impairment of MO to MAC maturation
might cause a deficient cytotoxic effector cell function
of intratumoral MAC derived from immigrated blood
MO. Furthermore, the suppression of CD16 expression
on cells of the MAC system by IFN-a could well
be considered the causative effect of the treatment of
steroid-resistant immune thrombocytopenia by IFN-a
[44].
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